Adeola Fakolade, Yetunde A. Onimode and Kayode Adedapo
Graves' disease is usually diagnosed as a syndrome of clinical and biochemical features including ophthalmopathy (TAO); the latter occurring in up to 50% of patients with the syndrome. The incidence of TAO is higher in females than in males, as with the parent syndrome (16:2.9 cases per 100 000 people annually). Onset is later in males, who also tend to have more severe cases and poorer prognosis. A 34 year-old male patient initially presented at the Eye Clinic with a three-month history of right-sided proptosis. Main findings were right proptosis of 3 mm, with no lid retraction or lag, nor impairment of vision. He was subsequently referred to the Endocrinology Clinic; there he was diagnosed with Graves' disease and placed on antithyroid medication. Ocular manifestations may be the first signs of Graves' disease, as occurred with this patient.
PDFShare this article
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
